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This work presents the development of a low cost sensor device for the diagnosis of breast 
cancer in point-of-care, made with new synthetic biomimetic materials inside plasticized 
poly(vinyl chloride), PVC, membranes, for subsequent potentiometric detection. This concept 
was applied to target a conventional biomarker in breast cancer: Breast Cancer Antigen 
(CA15-3). 
The new biomimetic material was obtained by molecularly-imprinted technology. In this, a 
plastic antibody was obtained by polymerizing around the biomarker that acted as an obstacle 
to the growth of the polymeric matrix. The imprinted polymer was specifically synthetized by 
electropolymerization on an FTO conductive glass, by using cyclic voltammetry, including 
40 cycles within -0.2 and 1.0 V. The reaction used for the polymerization included monomer 
(pyrrol, 5.0×10
-3
 mol/L) and protein (CA15-3, 100U/mL), all prepared in phosphate buffer 
saline (PBS), with a pH of 7.2 and 1% of ethylene glycol. The biomarker was removed from 
the imprinted sites by proteolytic action of proteinase K.  
The biomimetic material was employed in the construction of potentiometric sensors and 
tested with regard to its affinity and selectivity for binding CA15-3, by checking the 
analytical performance of the obtained electrodes. For this purpose, the biomimetic material 
was dispersed in plasticized PVC membranes, including or not a lipophilic ionic additive, and 
applied on a solid conductive support of graphite. The analytical behaviour was evaluated in 
buffer and in synthetic serum, with regard to linear range, limit of detection, repeatability, 
and reproducibility. 
This antibody-like material was tested in synthetic serum, and good results were obtained. 
The best devices were able to detect 5 times less CA15-3 than that required in clinical use. 
Selectivity assays were also performed, showing that the various serum components did not 
interfere with this biomarker. 
Overall, the potentiometric-based methods showed several advantages compared to other 
methods reported in the literature. The analytical process was simple, providing fast 
responses for a reduced amount of analyte, with low cost and feasible miniaturization. It also 
allowed the detection of a wide range of concentrations, diminishing the required efforts in 
previous sample pre-treating stages.  
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